Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease -: The task force on ACE-inhibitors of the European Society of Cardiolgy

被引：218

作者：

López-Sendón, J ^{[1
]}

Swedberg, K ^{[1
]}

McMurray, J ^{[1
]}

Tamargo, J ^{[1
]}

Maggioni, AP ^{[1
]}

Dargie, H ^{[1
]}

Tendere, M ^{[1
]}

Waagstein, F ^{[1
]}

Kjekshus, J ^{[1
]}

Lechat, P ^{[1
]}

Torp-Pedersen, C ^{[1
]}

机构：

[1] Univ Madrid, Hosp Gen Gregorio Maranon, E-28007 Madrid, Spain

来源：

关键词：

D O I：

10.1016/j.ehj.2004.06.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1454 / 1470

页数：17

共 112 条

[1] Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors
Ahuja, TS
Freeman, D
Mahnken, JD
Agraharkar, M
Siddiqui, M
Memon, A
[J]. AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (04) : 268 - 272
[2] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[3] *AM COLL CARD AM H, 2002, ACC AHA GUID EV MAN
[4] *AM COLLC ARD AM H, 1999, ACC AHA GUID MAN PAT
[5] THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION
AMBROSIONI, E
BORGHI, C
MAGNANI, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) : 80 - 85
[6] [Anonymous], 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]
[7] [Anonymous], 2000, Lancet, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7
[8] Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study
Arnold, JMO
Yusuf, S
Young, J
Mathew, J
Johnstone, D
Avezum, A
Lonn, E
Pogue, J
Bosch, J
[J]. CIRCULATION, 2003, 107 (09) : 1284 - 1290
[9] BALL SG, 1993, LANCET, V342, P821
[10] Beltman F, 1998, J HYPERTENS, V16, pS15